A Health Agency Signed Fifteen Years While Lab Tenants Sign Five

Put the two side by side. On Aug 28 this desk ran the collapse in life-sciences lease term — from roughly 90 months in 2022 to about 60 months today, with free rent running near a month for every year of term. Lab tenants are refusing to commit.

Here, a healthcare marketing business signs fifteen years and takes a third more space. Same end market, opposite behavior.

The difference is what each business needs the real estate to do. Lab space is a capital-intensive, purpose-built container whose value depends on a funding cycle the tenant does not control. Agency space is people. When headcount is the asset, long term is cheap insurance against a market where good, contiguous, transit-adjacent blocks are getting harder to assemble.

The five-floor, 254,118 sf configuration is the operative detail. Contiguity at that scale in the Grand Central district is scarce, and a tenant already holding it has more to lose by re-trading than by extending. Ownership converts an incumbent into a 2041 anchor; the tenant buys optionality it could not repurchase later at any obvious price.

Lease term is doing the work that headline rent used to do. Term is where conviction actually shows up, and it is diverging sharply by tenant business model rather than by submarket. Underwriting office demand at the sector level now misses the signal. The durable question is whether the tenant asset is equipment or people.